Browse > Article

Assessment of Occupational Exposure to Antineoplastic Agents in a Healthcare Setting  

Lee, Su-Mi (Department of Pharmaceutical Services, Samsung Medical Center)
Chung, Seon-Young (Department of Pharmaceutical Services, Samsung Medical Center)
Im, Hyun-Jeong (Department of Pharmaceutical Services, Samsung Medical Center)
Park, Hyo-Jung (Department of Pharmaceutical Services, Samsung Medical Center)
Lee, Su-Yun (Department of Pharmaceutical Services, Samsung Medical Center)
Jeon, Eun-Yong (Department of Pharmaceutical Services, Samsung Medical Center)
Sohn, Kie-Ho (Department of Pharmaceutical Services, Samsung Medical Center)
Publication Information
YAKHAK HOEJI / v.55, no.2, 2011 , pp. 81-90 More about this Journal
Abstract
Most antineoplastic agents are nonselective in their mechanism of action, affecting noncancerous as well as cancerous cells, and resulting in acute effects such as irritation of mucous membranes and chronic effects such as genotoxicity, teratogenicity, and carcinogenicity. Healthcare workers occupationally exposed to antineoplastic agents are at risk. The present study aimed to develop and apply methods to monitor occupational exposure to antineoplastic agents, using cyclophosphamide (CP) as the model compound. To monitor environmental and biological exposure, potentially contaminated surfaces were wiped and 24 hour urine samples were collected from workers. Liquid chromatography combined with tandem mass spectrometry was performed, with a limit of detection of 0.05 ng/ml. Measurable amounts of CP were detected on 92% of the sampled surfaces, with a geometric mean of 175.22 $ng/m^2$. Despite the environmental contamination of the model compound, CP was below the detection limit in all urine samples. If workplace contamination cannot be completely avoided, it is importance to reduce exposure to the lowest possible levels. To this aim, efforts to minimize occupational exposure along with biological and environmental monitoring are required. The standardized sampling techniques, and specific and sensitive analytical methods reported in this study may be helpful in assessing occupational exposure and devising strategies to reduce exposure.
Keywords
antineoplastic drugs; biological monitoring; hospital work environment; surface contamination;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Connor, T. H. and McDiarmid, M. A. : Preventing occupational exposures to antineoplastic drugs in health care settings. CA Cancer. J. Clin. 56, 354 (2006).   DOI   ScienceOn
2 Hansel, S., Castegnaro, M., Sportouch, M. H. et al. : Chemical degradation of wastes of antineoplastic agents: cyclophosphamide, ifosfamide, and melphalan. Int. Arch. Occup. Environ. Health 69, 109 (1997).
3 Connor, T. H., Shults, M. and Fraser, M. P. : Determination of the vaporization of solutions of mutagenic antineoplastic agents at 23 and 37 degrees using a desiccator technique. Mutat. Res. 470, 85 (2000).   DOI   ScienceOn
4 Hedmer, M., Jonsson, B. A. and Nygren, O. : Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces. J. Environ. Monit. 6, 979 (2004).   DOI   ScienceOn
5 Harrison, B. R. : Safety handling cytotoxic drugs. The chemotherapy source book. 2nd ed. Williams & Wilkins, 905-945 (1996).
6 Sottani, C., Turci, R., Perbellini, L. and Minoia, C. : Liquidliquid extraction procedure for trace determination of cyclophosphamide in human urine by high-performance liquid chromatography tandem mass spectrometry. Rapid Commun. Mass. Spectrom. 12, 1063 (1998).   DOI   ScienceOn
7 Turci, R. and Minoia, C. : Residual hazard assessment related to handling of antineoplastic drugs: safety system evolution and quality assurance of analytical measurement. Ann. N Y Acad. Sci. 1076, 649 (2006).   DOI   ScienceOn
8 김봉임 : 항암제 취급간호사의 항암제 체내흡수에 관한 조사. 간호학회지 27, 520 (1997).
9 최봉규 : 종합병원 근무 간호사와 약사의 항암제 노출에 관한 연구. 석사학위논문, 서울대학교 (1999).
10 Turci, R., Sottani, C., Spagnoli, G. and Minoia, C. : Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 789, 169 (2003).   DOI   ScienceOn
11 신혜숙, 이세훈 : 간호사에서 항암제 취급양상과 건강증상. 대한산업의학지 8, 228 (1996).
12 IARC (International Agency for Research on Cancer) : IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Lyons, France (2004).
13 Product Information: Cytoxan(R), cyclophosphamide. Bristol-Myers Squibb, Princeton, NJ, USA.
14 Hedmer, M., Hoglund, P., Cavallin-Stahl, E., Albin, M. and Jonsson, B. A. : Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients. Int. Arch. Occup. Environ. Health 81, 285 (2008).
15 김소정 : 항암제에 폭로된 간호사들의 염색체 이상과 자매염색체 교환빈도. 석사학위논문, 서울대학교 (1995).
16 김봉임 : 항암제 취급 간호사의 소변중 돌연변이 유발능과 자각증상 및 스트레스. 박사학위논문, 경북대학교 (1996).
17 McDevitt, J., Lees, P. and McDiarmid, M. : Exposure of hospital pharmacists and nurses to antineoplastic drugs. J. Occup. Med. 35, 57 (1993).
18 Sessink, P. J. M., Van der Kerkhof, M. C. A., Anzion, R. B. M., Noordhoek, J. and Bos, R. P. : Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route? Arch. Environ. Health 49, 165 (1994).   DOI   ScienceOn
19 Larson, R. R., Khazaeli, M. B. and Dillon, H. K. : Monitoring method for surface contamination caused by selected antineoplastic agents. Am. J. Health Syst. Pharm. 59, 270 (2002).
20 Sessink, P. J. M., Wittenhorst, B. C., Anzion, R. B. and Bos, R. P. : Exposure of pharmacy technicians to antineoplastic agents - reevaluation after additional protective measures. Arch. Environ. Health 52, 240 (1997).   DOI   ScienceOn
21 Pethran, A., Schierl, R., Hauff, K., Grimm, C. H., Boos, K. S. and Nowak, D. : Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations. Int. Arch. Occup. Environ. Health 76, 5 (2003).
22 Hedmer, M., Georgiadi, A., Bremberg, E. R., Jonsson, B. A. and Eksborg, S. : Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden. Ann. Occup. Hyg. 49, 629 (2005).   DOI   ScienceOn
23 Fransman, W., Peelen, S., Hilhorst, S., Roeleveld, N., Heederik, D. and Kromhout, H. : A pooled analysis to study trends in exposure to antineoplastic drugs among nurses. Ann. Occup. Hyg. 51, 231 (2007).
24 Hedmer, M., Tinnerberg, H., Axmon, A. and Jonsson, B. A. : Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital. Int. Arch. Occup. Environ. Health 81, 899 (2008).   DOI   ScienceOn
25 Sessink, P. J. M., Boer, K. A., Scheefhals, A. P. H., Anzion, R. B. M. and Bos, R. P. : Occupational exposure to antineoplastic agents at several departments in a hospital: environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. Int. Arch. Occup. Environ. Health 64, 105 (1992).   DOI   ScienceOn
26 Castiglia, L., Miraglia, N., Pieri, M., Simonelli, A., Basilicata, P., Genovese, G., Guadagni, R., Acampora, A., Sannolo, N. and Scafarto, M. V. : Evaluation of occupational exposure to antiblastic drugs in an Italian hospital oncological department. J. Occup. Health 50, 48 (2008).   DOI   ScienceOn
27 Martins, I., Apostoli, P. and Della Rosa, H. V. : Cyclophosphamide levels in sites of preparation and administration of antineoplastic drugs. Lat. Am. J. Pharm. 27, 217 (2008).
28 Yoshida, J., Tei, G., Mochizuki, C., Masu, Y., Koda, S. and Kumagai, S. : Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment. Ann. Occup. Hyg. 53, 153 (2009).   DOI   ScienceOn
29 Soave, C., Giuliari, C., Bartolucci, G. B., Carrieri, M., Festa, D., Sannolo, N., Miraglia, N., Acampora, A. and Viotti, P. L. : Cyclophosphamide environmental contamination in drug reconstitution units in twenty one Italian hospitals. EJHP 6, 15 (2003).
30 Wick, C., Slawson, M. H., Jorgenson, J. A. and Tyler, L. S. : Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. Am. J. Health Syst. Pharm. 60, 2314 (2003).
31 Connor, T. H., Anderson, R. W., Sessink, P. J., Broadfield, L. and Power, L. A. : Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States. Am. J. Health Syst. Pharm. 56, 1427 (1999).
32 Mason, H. J., Blair, S., Sams, C., Jones, K., Garfitt, S. J., Cuschieri, M. J. and Baxter, P. J. : Exposure to Antineoplastic drugs in two UK hospital pharmacy units. Ann. Occup. Hyg. 49, 603 (2005).   DOI   ScienceOn
33 Acampora, A., Castiglia, L., Miraglia, N., Pieri, M., Soave, C., Liotti, F. and Sannolo, N. : A case study: surface contamination of cyclophosphamide due to working practices and cleaning procedures in two Italian hospitals. Ann. Occup. Hyg. 49, 611 (2005).   DOI   ScienceOn
34 IARC (International Agency for Research on Cancer) : IARC monographs: chemicals and industrial processes associated with cancer in humans. Lyons, France (1979).
35 Falck, K., Grohn, P., Sorsa, M., Vainio, H., Heinonen, E. and Holsti, L. R. : Mutagenicity in urine of nurses handling cytostatic drugs. Lancet. 1, 1250 (1979).
36 Sessink, P. J. M., Anzion, R. B. M., Van der Broek, P. H. H. and Bos, R. P. : Detection of contamination with antineoplastic agents in a hospital pharmacy department. Pharm. Week. Sci. 14, 16 (1992).   DOI   ScienceOn
37 Schmaus, G., Schierl, R. and Funck, S. : Monitoring surface contamination by antineoplastic drugs using gas chromatography mass spectrometry and voltammetry. Am. J. Health Syst. Pharm. 59, 956 (2002).
38 ASHP (American Society of Hospital Pharmacists) : ASHP guidelines on handling hazardous drug. Am. J. Health-Syst. Pharm. 63, 1172 (2006).   DOI   ScienceOn
39 NIOSH (National Institute for Occupational Safety and Health) : NIOSH alert: Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. www.cdc.gov/niosh/docs/ 2004-165/.
40 Sessink, P. J. M. and Bos, R. P. : Drugs hazardous to healthcare workers: evaluation of methods for monitoring occupational exposure to cytostatic drugs. Drug. Saf. 20, 347 (1999).   DOI   ScienceOn
41 Touzin, K., Bussieres, J. F., Langlois, E., Lefebvre, M. and Gallant, C. : Cyclophosphamide contamination observed on the external surfaces of drug vials and the efficacy of cleaning on vial contamination. Ann. Occup. Hyg. 52, 765 (2008).   DOI   ScienceOn
42 ASHP (American Society of Hospital Pharmacists) : ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am. J. Hosp. Pharm. 47, 1033 (1990).
43 Dranitsaris, G., Johnston, M., Poirier, S., Schueller, T., Milliken, D., Green, E. and Zanke, B. : Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature. J. Oncol. Pharm. Pract. 11, 69 (2005).   DOI   ScienceOn
44 Sessink, P. J., Kroese, E. D., van Kranen, H. J. and Bos, R. P. : Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide. Int. Arch. Occup. Environ. Health 67, 317 (1995).   DOI   ScienceOn
45 Mason, H. J., Morton, J., Garfitt, S. J., Iqbal, S. and Jones, K. : Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy. Ann. Occup. Hyg. 47, 681 (2003).   DOI   ScienceOn
46 Connor, T. H., Sessink, P. J., Harrison, B. R., Pretty, J. R., Peters, B. G., Alfaro, R. M., Bilos, A., Beckmann, G., Bing, M. R., Anderson, L. M. and Dechristoforo, R. : Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies. Am. J. Health Syst. Pharm. 62, 475 (2005).